...this month. Bioxyne also said it will consider out-licensing HI-164OV for other indications. In March, Probiomics Ltd....

...the ASX on April 4 (see BioCentury, Jan. 2). Hunter Immunology Ltd. , Sydney, Australia Probiomics Ltd....

...Hunter's board recommended that shareholders accept an October merger offer from probiotics company Probiomics. The stock...
...Hunter, an unlisted public company, at about A$29.7 million ($29.4 million). Details were not disclosed. Probiomics...
...June 30, 2011. The deal, which is subject to Probiomics shareholder approval as well as Probiomics...

...Denmark BNY 12/23/02 Chemgenex OTC CXSFY Australia BNY 12/6/02 Roche OTC RHHBY Switzerland BNY 12/5/02 VRI Biomedical...